125 related articles for article (PubMed ID: 15523596)
1. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus.
Schäffler A; Büchler C; Müller-Ladner U; Herfarth H; Ehling A; Paul G; Schölmerich J; Zietz B
Horm Metab Res; 2004 Oct; 36(10):702-7. PubMed ID: 15523596
[TBL] [Abstract][Full Text] [Related]
2. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
Pfützner A; Langenfeld M; Kunt T; Löbig M; Forst T
Clin Lab; 2003; 49(11-12):571-6. PubMed ID: 14651328
[TBL] [Abstract][Full Text] [Related]
4. Increased serum resistin levels in patients with type 2 diabetes are not linked with markers of insulin resistance and adiposity.
Hasegawa G; Ohta M; Ichida Y; Obayashi H; Shigeta M; Yamasaki M; Fukui M; Yoshikawa T; Nakamura N
Acta Diabetol; 2005 Jun; 42(2):104-9. PubMed ID: 15944845
[TBL] [Abstract][Full Text] [Related]
5. Identification of influencing variables on adiponectin serum levels in diabetes mellitus type 1 and type 2.
Schäffler A; Herfarth H; Paul G; Ehling A; Müller-Ladner U; Schölmerich J; Zietz B
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):383-9. PubMed ID: 15239024
[TBL] [Abstract][Full Text] [Related]
6. Serum resistin levels in Syrian obese patients with diabetes mellitus type II.
Al-Sari IE; Al-Quobaili FA; Kabalan YM
Saudi Med J; 2007 Dec; 28(12):1890-4. PubMed ID: 18060223
[TBL] [Abstract][Full Text] [Related]
7. Circulating resistin concentrations in children depend on renal function.
Nüsken KD; Kratzsch J; Wienholz V; Stöhr W; Rascher W; Dötsch J
Nephrol Dial Transplant; 2006 Jan; 21(1):107-12. PubMed ID: 16144855
[TBL] [Abstract][Full Text] [Related]
8. Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus.
Hui-Bing H; Migita K; Miyashita T; Maeda Y; Nakamura M; Yatsuhashi H; Ishibashi H; Eguchi K; Kimura H
Metabolism; 2006 Dec; 55(12):1670-3. PubMed ID: 17142142
[TBL] [Abstract][Full Text] [Related]
9. Serum resistin is not associated with obesity or insulin resistance in humans.
Iqbal N; Seshadri P; Stern L; Loh J; Kundu S; Jafar T; Samaha FF
Eur Rev Med Pharmacol Sci; 2005; 9(3):161-5. PubMed ID: 16080635
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
[TBL] [Abstract][Full Text] [Related]
11. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
12. Serum resistin is associated with the severity of microangiopathies in type 2 diabetes.
Osawa H; Ochi M; Kato K; Yamauchi J; Nishida W; Takata Y; Kawamura R; Onuma H; Takasuka T; Shimizu I; Fujii Y; Ohashi J; Makino H
Biochem Biophys Res Commun; 2007 Apr; 355(2):342-6. PubMed ID: 17303077
[TBL] [Abstract][Full Text] [Related]
13. Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.
Osawa H; Onuma H; Ochi M; Murakami A; Yamauchi J; Takasuka T; Tanabe F; Shimizu I; Kato K; Nishida W; Yamada K; Tabara Y; Yasukawa M; Fujii Y; Ohashi J; Miki T; Makino H
Biochem Biophys Res Commun; 2005 Sep; 335(2):596-602. PubMed ID: 16087164
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
[TBL] [Abstract][Full Text] [Related]
15. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
Osawa H; Ochi M; Tabara Y; Kato K; Yamauchi J; Takata Y; Nishida W; Onuma H; Shimizu I; Fujii Y; Miki T; Ohashi J; Makino H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):74-80. PubMed ID: 18081734
[TBL] [Abstract][Full Text] [Related]
16. Serum resistin in acute myocardial infarction patients with and without diabetes mellitus.
Korah TE; Ibrahim HH; Badr EA; ElShafie MK
Postgrad Med J; 2011 Jul; 87(1029):463-7. PubMed ID: 21447495
[TBL] [Abstract][Full Text] [Related]
17. Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.
Chen CC; Li TC; Li CI; Liu CS; Wang HJ; Lin CC
Metabolism; 2005 Apr; 54(4):471-5. PubMed ID: 15798953
[TBL] [Abstract][Full Text] [Related]
18. Serum resistin levels in patients with type 2 diabetes mellitus and its relationship with body composition.
Habib SS
Saudi Med J; 2012 May; 33(5):495-9. PubMed ID: 22588809
[TBL] [Abstract][Full Text] [Related]
19. [The relationship between resistin and the peripheral neuropathy in type 2 diabetes].
Wang XH; Wang DQ; Chen SH; Zhang L; Ni YH
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1755-7. PubMed ID: 17919381
[TBL] [Abstract][Full Text] [Related]
20. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus.
Youn BS; Yu KY; Park HJ; Lee NS; Min SS; Youn MY; Cho YM; Park YJ; Kim SY; Lee HK; Park KS
J Clin Endocrinol Metab; 2004 Jan; 89(1):150-6. PubMed ID: 14715842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
